Samuel Callisto, Ph.D.
Research Scientist II
Samuel joined MetrumRG in 2019 after earning his PhD in Experimental and Clinical Pharmacology with an emphasis in Pharmacometrics from the University of Minnesota College of Pharmacy. His thesis work focused on modeling cognitive side effects of the anti-epileptic drug topiramate using a combination of pharmacokinetic-pharmacodynamic models and unsupervised machine learning algorithms. While in graduate school he also researched the impact of pharmacogenomics on the pharmacokinetics and pharmacodynamics of multiple drug classes.